课题基金 / 基金详情

槲皮素靶向上调TLE4阻断Wnt/β-catenin信号通路抑制宫颈癌细胞的迁移及侵袭

批准号:
82104464
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
李媛媛
依托单位:
学科分类:
中药抗肿瘤药理
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
李媛媛

项目摘要

结项摘要

相似基金

相关文献

中文摘要
宫颈癌是一种严重威胁女性健康的恶性肿瘤。中药有效成分槲皮素是一种潜在的宫颈癌抗肿瘤药物,然其作用机制复杂,需要进一步深入探索。结合GEO数据库及RNA-seq分析,发现Wnt通路转录抑制关键因子之一TLE4在宫颈癌中低表达,槲皮素处理后显著上调。前期实验显示:①槲皮素及过表达TLE4抑制宫颈癌细胞的迁移;②槲皮素靶向上调TLE4表达,可以阻断Wnt/β-catenin信号通路;③AR转录激活TLE4表达。因此提出科学假说:槲皮素处理宫颈癌细胞后,可能与AR蛋白分子对接,AR表达上升,转录激活TLE4表达,TLE4在核内形成转录抑制复合物,抑制Wnt/β-catenin信号通路,从而抑制宫颈癌细胞的迁移及侵袭。本项目拟从临床标本、体外细胞及体内动物实验三个层面,利用基因表达调控、Transwell、Co-IP、质谱测序、荧光共聚焦等技术阐明以上科学假说,为槲皮素治疗宫颈癌提供理论及实验依据。
英文摘要
Cervical cancer is a malignant tumor that seriously threatens women's health. Chinese native medicine effective component quercetin is a potential antitumor drug for cervical cancer, however, its mechanism is complicated and needs to be further explored. Combined with the GEO database and RNA-seq analysis, we found that TLE4, one of the key transcription repressors of the Wnt pathway, was low expressed in cervical cancer and significantly up-regulated after quercetin treatment. Previous experiments showed that: ①quercetin and overexpression of TLE4 inhibited the migration of cervical cancer cells; ②quercetin up-regulated the expression of TLE4, and block the Wnt/β-catenin signaling pathway; ③AR transcription activated TLE4 expression. Therefore, the scientific hypothesis was proposed: after treating cervical cancer cells with quercetin, quercetin might molecule docking AR protein, the expression of AR increased, transcription activated the expression of TLE4, TLE4 in the nucleus to form the transcription repressor complex, and inhibit the Wnt/β-catenin signaling pathway, thereby inhibiting cell migration and invasion of cervical cancer cells. This project intends to clarify the above scientific hypotheses from the three levels of clinical specimens, in vitro cells and in vivo animal experiments by using gene expression regulation, Transwell, Co-IP, mass spectrometry sequencing, fluorescence confocal, and other methods, to provide the theoretical and experimental basis for the treatment of cervical cancer with quercetin.
中药有效成分槲皮素是一种潜在的宫颈癌抗肿瘤药物,其作用机制复杂,课题组深入探索了槲皮素抑制宫颈癌细胞迁移及侵袭的机制。研究结果如下:①免疫组化检测临床样本,在胞核中TLE4及AR在宫颈癌表达显著低于正常宫颈组织;TLE4在宫颈癌中mRNA表达水平较正常宫颈显著下降,显示TLE4及AR在宫颈癌中起着抑制肿瘤的作用。②构建了TLE4过表达及敲除细胞株,TLE4过表达后细胞迁移及侵袭能力显著减弱,TLE4敲除后迁移及侵袭能力显著增强,显示了TLE4可以抑制宫颈癌细胞的迁移及侵袭能力,EMT相关因子也有相应的变化;③槲皮素靶向上调TLE4抑制Wnt/β-catenin信号通路。过表达TLE4细胞中,HDAC1表达上升,β-catenin、TCF4及下游蛋白表达下降;敲除TLE4细胞中,β-catenin、TCF1、TCF4及下游蛋白表达上升。Co-IP实验富集TLE4结合蛋白,检测结果显示:TLE4与Wnt5a及β-catenin有结合作用;槲皮素处理后,TLE4表达上升,β-catenin、TCF4蛋白表达下降,TLE4与Wnt5a、β-catenin结合减弱。④ 体内裸鼠成瘤实验显示:与模型组相比,槲皮素低、高、纳米材料高剂量组成瘤体积显著降低,脂质体水凝胶纳米材料提高了槲皮素的生物利用度;过表达TLE4的SiHa细胞成瘤体积显著减小。⑤AR转录调控TLE4的表达。构建稳定过表达野生型及突变型AR细胞株,过表达AR后TLE4表达上升,突变AR后TLE4表达显著降低;AR抑制剂比卡鲁胺处理Ca Ski细胞后,AR及TLE4的mRNA及蛋白水平显著下降。⑥槲皮素与AR蛋白存在分子对接作用。课题组从临床标本、体外细胞及体内动物实验层面探讨槲皮素靶向上调TLE4阻断Wnt/β-catenin 信号通路抑制宫颈癌细胞迁移及侵袭的分子机制,为槲皮素在宫颈癌的临床应用提供理论及实验依据。
国内基金
海外基金